Research-Grade Vasodilator Compound Overview
Minoxidil Dragon Pharma is a research-grade potassium channel opener and peripheral vasodilator originally developed for cardiovascular research applications. This compound operates through selective activation of ATP-sensitive potassium channels in vascular smooth muscle, leading to membrane hyperpolarisation and subsequent vasodilation in experimental models. Laboratory researchers investigating circulatory physiology and vascular biology will find this formulation valuable for controlled studies examining blood flow regulation and cardiovascular response mechanisms. When sourcing quality research compounds, many UK laboratories trust Stroid UK Shop for consistent pharmaceutical-grade materials.
Laboratory Research Applications
Researchers studying cardiovascular physiology commonly examine minoxidil’s effects on vascular resistance and arterial smooth muscle function in animal models. The compound demonstrates potent vasodilatory properties through its mechanism of action on potassium channels, making it valuable for investigations into hypertension models and peripheral circulation studies. Scientists working with cardiovascular research compounds often utilise this material to study dose-response relationships in vascular smooth muscle preparations. Additionally, dermatological researchers investigate minoxidil’s effects on follicular blood supply and microcirculation patterns in controlled experimental settings. The compound’s dual applications in both cardiovascular and dermatological research make it particularly valuable for laboratories studying vascular biology across multiple organ systems, complementing other research areas such as selective androgen receptor modulator studies and peptide research programmes.
Technical Specifications
| Chemical Name | 2,4-Diamino-6-piperidinopyrimidine 3-oxide |
|---|---|
| CAS Number | 38304-91-5 |
| Molecular Formula | C₉H₁₅N₅O |
| Molecular Weight | 209.25 g/mol |
| Purity | Verify with supplier |
| Storage | Room temperature, dry conditions |
| Stability | Stable under recommended storage |
Research Compliance Statement
This Minoxidil Dragon Pharma formulation is manufactured exclusively for in-vitro laboratory research and experimental applications. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure appropriate institutional approvals, safety protocols, and regulatory compliance when handling this material. Laboratory personnel should consult relevant safety data sheets and implement proper handling procedures during experimental procedures. This compound is supplied solely for qualified research institutions and licensed laboratories conducting legitimate scientific investigations.
